Search research articles
Contact Us
Filters
Showing results (21-30 of 36) with videos related to
Page
of 4
Sort By:
Psychopharmacology
|
September 23, 2008
The discriminative stimulus effects of dopamine D2- and D3-preferring agonists in rats
Mikhail N Koffarnus, Benjamin Greedy, Stephen M Husbands, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 25, 2010
Dopamine D3 and D2 receptor mechanisms in the abuse-related behavioral effects of cocaine: studies with preferential antagonists in squirrel monkeys
Cindy Achat-Mendes, Peter Grundt, Jianjing Cao, et al.
Journal of Medicinal Chemistry
|
April 1, 2009
N-(4-(4-(2,3-dichloro- or 2-methoxyphenyl)piperazin-1-yl)butyl)heterobiarylcarboxamides with functionalized linking chains as high affinity and enantioselective D3 receptor antagonists
Amy Hauck Newman, Peter Grundt, George Cyriac, et al.
Journal of Psychopharmacology (Oxford, England)
|
February 10, 2010
PG01037, a novel dopamine D3 receptor antagonist, inhibits the effects of methamphetamine in rats
Amanda E Higley, Krista Spiller, Peter Grundt, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 19, 2005
Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior
Gregory T Collins, Jeffrey M Witkin, Amy H Newman, et al.
Experimental and Clinical Psychopharmacology
|
August 8, 2012
Cocaine self-administration in dopamine D₃ receptor knockout mice
S Barak Caine, Morgane Thomsen, Andrew C Barrett, et al.
Psychopharmacology
|
July 15, 2010
Imaging brain regional and cortical laminar effects of selective D3 agonists and antagonists
Ji-Kyung Choi, Joseph B Mandeville, Y Iris Chen, et al.
Journal of Medicinal Chemistry
|
February 4, 2005
Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor
Peter Grundt, Erin E Carlson, Jianjing Cao, et al.
Journal of Medicinal Chemistry
|
December 4, 2003
Guanidino N-substituted and N,N-disubstituted derivatives of the kappa-opioid antagonist GNTI
Shannon L Black, Cedric Chauvignac, Peter Grundt, et al.
Psychopharmacology
|
March 30, 2007
Yawning and hypothermia in rats: effects of dopamine D3 and D2 agonists and antagonists
Gregory T Collins, Amy Hauck Newman, Peter Grundt, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 36) with videos related to
Sort By:
Page
of 4
Psychopharmacology
|
September 23, 2008
The discriminative stimulus effects of dopamine D2- and D3-preferring agonists in rats
Mikhail N Koffarnus, Benjamin Greedy, Stephen M Husbands, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 25, 2010
Dopamine D3 and D2 receptor mechanisms in the abuse-related behavioral effects of cocaine: studies with preferential antagonists in squirrel monkeys
Cindy Achat-Mendes, Peter Grundt, Jianjing Cao, et al.
Journal of Medicinal Chemistry
|
April 1, 2009
N-(4-(4-(2,3-dichloro- or 2-methoxyphenyl)piperazin-1-yl)butyl)heterobiarylcarboxamides with functionalized linking chains as high affinity and enantioselective D3 receptor antagonists
Amy Hauck Newman, Peter Grundt, George Cyriac, et al.
Journal of Psychopharmacology (Oxford, England)
|
February 10, 2010
PG01037, a novel dopamine D3 receptor antagonist, inhibits the effects of methamphetamine in rats
Amanda E Higley, Krista Spiller, Peter Grundt, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 19, 2005
Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior
Gregory T Collins, Jeffrey M Witkin, Amy H Newman, et al.
Experimental and Clinical Psychopharmacology
|
August 8, 2012
Cocaine self-administration in dopamine D₃ receptor knockout mice
S Barak Caine, Morgane Thomsen, Andrew C Barrett, et al.
Psychopharmacology
|
July 15, 2010
Imaging brain regional and cortical laminar effects of selective D3 agonists and antagonists
Ji-Kyung Choi, Joseph B Mandeville, Y Iris Chen, et al.
Journal of Medicinal Chemistry
|
February 4, 2005
Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor
Peter Grundt, Erin E Carlson, Jianjing Cao, et al.
Journal of Medicinal Chemistry
|
December 4, 2003
Guanidino N-substituted and N,N-disubstituted derivatives of the kappa-opioid antagonist GNTI
Shannon L Black, Cedric Chauvignac, Peter Grundt, et al.
Psychopharmacology
|
March 30, 2007
Yawning and hypothermia in rats: effects of dopamine D3 and D2 agonists and antagonists
Gregory T Collins, Amy Hauck Newman, Peter Grundt, et al.
Page
of 4